tiprankstipranks
Trending News
More News >
Scpharmaceuticals (SCPH)
:SCPH
US Market

scPharmaceuticals (SCPH) Financial Statements

Compare
490 Followers

scPharmaceuticals Financial Overview

scPharmaceuticals's market cap is currently $133.00M. The company's EPS TTM is $-1.907; its P/E ratio is ―; scPharmaceuticals is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 36.33M$ 13.59M$ 0.00$ 0.00$ 0.00
Gross Profit$ 24.97M$ 9.78M$ -468.00K$ -438.00K$ -399.00K
Operating Income$ -64.78M$ -55.40M$ -36.16M$ -25.82M$ -29.93M
EBITDA$ -77.56M$ -46.06M$ -33.07M$ -25.02M$ -29.22M
Net Income$ -85.15M$ -54.81M$ -37.52M$ -30.49M$ -34.39M
Balance Sheet
Cash & Short-Term Investments$ 75.66M$ 76.01M$ 118.37M$ 75.46M$ 105.28M
Total Assets$ 107.52M$ 94.48M$ 124.19M$ 79.04M$ 109.05M
Total Debt$ 52.69M$ 40.27M$ 37.37M$ 17.64M$ 20.21M
Net Debt$ -22.96M$ -6.54M$ -33.69M$ -56.63M$ -85.07M
Total Liabilities$ 94.20M$ 57.26M$ 51.76M$ 22.57M$ 26.88M
Stockholders' Equity$ 13.32M$ 37.22M$ -226.54M$ -189.70M$ -161.66M
Cash Flow
Free Cash Flow$ -70.56M$ -59.28M$ -34.60M$ -27.16M$ -27.69M
Operating Cash Flow$ -70.54M$ -59.24M$ -34.58M$ -27.15M$ -27.69M
Investing Cash Flow$ 29.30M$ 19.96M$ -45.86M$ 32.13M$ -33.46M
Financing Cash Flow$ 70.08M$ 14.85M$ 77.23M$ -2.53M$ 60.35M
Currency in USD

scPharmaceuticals Earnings and Revenue History

scPharmaceuticals Debt to Assets

scPharmaceuticals Cash Flow

scPharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis